FORMER TOP A*STAR SCIENTISTS LAUNCH ABASIA, A SINGAPORE-BASED REAGENTS MANUFACTURER, TO SUPPORT INCREASED TESTING LOCALLY
As COVID-19 testing becomes part of Singapores new normal, locally based AbAsia is poised to ensure Singapore has a consistent supply of critical reagents to make COVID-19 test kits.
- As COVID-19 testing becomes part of Singapores new normal, locally based AbAsia is poised to ensure Singapore has a consistent supply of critical reagents to make COVID-19 test kits.
- This will help the country meet the growing demand for COVID-19 in-vitro diagnostic kits and polymerase chain reaction (PCR) test kits.
- The companys high quality, reliable and accessible reagents will also be used to drive advances in R&D in biotechnology and cancer research in the future.
- This venture will also support the country as we seek to roll out routine and large-scale testing to keep the country safe.